Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
pharmaceutical_companies:moderna [2023/06/05 20:13]
liam
pharmaceutical_companies:moderna [2023/06/05 20:14] (current)
liam
Line 7: Line 7:
 ===== History ===== ===== History =====
  
-Moderna began collaborating with [[alexion|Alexion Pharmaceuticals]] in January 2014, entering an agreement for ten product options based on Moderna's mRNA platform.((//Elpidera.// (2016). Moderna Therapeutics. https://archive.ph/uennQ)) ((Reidy, C. (2014, January 13). //Alexion, Moderna announce agreement to develop messenger RNA therapeutics.// Boston Globe Media Partners. https://web.archive.org/web/20230605072835/https://www.boston.com/news/innovation/2014/01/13/alexion-moderna-announce-agreement-to-develop-messenger-rna-therapeutics/)) On January 14, 2014, Moderna announced the creation of Onkaido Therapeutics to focus "exclusively on developing mRNA-based oncology treatments."[3][4]+Moderna began collaborating with [[alexion|Alexion Pharmaceuticals]] in January 2014, entering an agreement for ten product options based on Moderna's mRNA platform.((//Elpidera.// (2016). Moderna Therapeutics. https://archive.ph/uennQ)) ((Reidy, C. (2014, January 13). //Alexion, Moderna announce agreement to develop messenger RNA therapeutics.// Boston Globe Media Partners. https://web.archive.org/web/20230605072835/https://www.boston.com/news/innovation/2014/01/13/alexion-moderna-announce-agreement-to-develop-messenger-rna-therapeutics/)) On January 14, 2014, Moderna announced the creation of [[Onkaido Therapeutics]] to focus "exclusively on developing mRNA-based [[:oncology]] treatments."((Favorito, M. (2014, January 14). //Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA TherapeuticsTM in Oncology with $20 Million Capital Commitment.// Moderna Therapeutics. http://archive.today/2016.11.20-035524/http://www.modernatx.com/news-events/press-releases/moderna-launches-onkaido-therapeutics-focus-development-mrna-therapeuticstm)) ((Gormley, B. (2014, January 15). //Moderna Launches Cancer Drug Co. Onkaido Therapeutics With $20M Investment.// Wall Street Journal. http://archive.today/2023.06.05-073743/https://www.wsj.com/amp/articles/DJFVW00020140114ea1eqwhzn))
  
 On January 8, 2015, Moderna announced the launch of its second spinoff company, Valera, "focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases."[5] On January 8, 2015, Moderna announced the launch of its second spinoff company, Valera, "focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases."[5]
Back to top